2036 Trademark

Trademark Overview


On Thursday, May 11, 2006, a trademark application was filed for 2036 with the United States Patent and Trademark Office. The USPTO has given the 2036 trademark a serial number of 78881284. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, April 24, 2008. This trademark is owned by Kindway International Limited. The 2036 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, veterinary, and sanitary preparations, all used for the treatment of infectious diseases, namely, respiratory infections, eye infections, for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transm...
2036

General Information


Serial Number78881284
Word Mark2036
Filing DateThursday, May 11, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, April 24, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2007

Trademark Statements


Goods and ServicesPharmaceutical, veterinary, and sanitary preparations, all used for the treatment of infectious diseases, namely, respiratory infections, eye infections, for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, for the treatment of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, for use in ophthalmology, for the treatment of dental and oral diseases, for use in gastroenterology; for the treatment of the respiratory system, for use in ocular disorders, for the treatment of cardiovascular diseases, acne medication, allergy medication, antacids, anthelmintics, anti-arrhythmics, antibiotic creams and ointments, antibiotics, anticoagulants, anticonvulsants, antidepressants, antiemetics, antiflatulants, antihistamines, antihypertensives anti-infectives, anti-inflammatories, antiparasites, antivirals, burn relief medications, calcium channels blockers, central nervous system depressants, central nervous system stimulants, cough treatment medication, diarrhea medication, fungal medications, gastro-intestinal pharmaceutical preparations, glaucoma agents, hydrocortisone, hypnotic agents, sedatives; dietetic substances, namely foods, adapted for medical use; vitamin supplements, mineral food supplements; herbal extracts for medical purposes; medicated extracts of plants and herbs in the form of capsules, tablets, liquid concentrate, powder, and crystals; dietetic supplements for medical use and nutritious health food supplement for medical use all made primarily of lingzhi spores, lingzhi spore lipids, yunzhi, bee glue or propolis, or cordyceps or extracts therefrom; lingzhi granules, lingzhi pills, lingzhi capsules, lingzhi tablets; and medicinal tea made primarily of lingzhi spores; Chinese herbal medicines, and Chinese patent medicines all composed of lingzhi spores, lingzhi spore lipids, yunzhi, bee glue, propolis, or cordyceps, and used for the treatment of infectious diseases, namely, respiratory infections, eye infections, for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, for the treatment of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, for use in ophthalmology, for the treatment of dental and oral diseases, for use in gastroenterology, for the treatment of the respiratory system, for use in ocular disorders, for the treatment of cardiovascular diseases, acne medication, allergy medication, antacids, anthelmintics, anti-arrhythmics, antibiotic creams and ointments, antibiotics, anticoagulants, anticonvulsants, antidepressants, antiemetics, antiflatulants, antihistamines, antihypertensives anti-infectives, anti-inflammatories, antiparasites, antivirals, burn relief medications, calcium channels blockers, central nervous system depressants, central nervous system, stimulants, cough treatment medication, diarrhea medication, fungal medications, gastro-intestinal pharmaceutical preparations, glaucoma agents, hydrocortisone, hypnotic agents, sedatives
Pseudo MarkTWO THOUSAND THIRTY-SIX

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 17, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKindway International Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHong Kong
HK

Party NameKindway International Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHong Kong
HK

Trademark Events


Event DateEvent Description
Wednesday, June 25, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Wednesday, June 25, 2008ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 23, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2007NOTICE OF PUBLICATION
Thursday, May 10, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 2, 2007ASSIGNED TO LIE
Thursday, April 12, 2007EXAMINERS AMENDMENT MAILED
Thursday, April 12, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 12, 2007EXAMINER'S AMENDMENT ENTERED
Thursday, April 12, 2007EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 10, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 9, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 9, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 16, 2006NON-FINAL ACTION MAILED
Monday, October 16, 2006NON-FINAL ACTION WRITTEN
Saturday, October 14, 2006ASSIGNED TO EXAMINER
Monday, June 26, 2006PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, June 26, 2006TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, May 17, 2006NEW APPLICATION ENTERED IN TRAM